We mapped out the key changes among Walmart's healthcare leadership

Hello,

Welcome to Insider Healthcare. I’m Lydia Ramsey Pflanzer, and today in healthcare news:

  • We mapped out some of the key healthcare leadership changes at Walmart;
  • Experts shared what Moderna’s up against as it aims to develop an HIV vaccine;
  • Primary-care upstarts are protesting the decision to halt direct contracting applications.

If you’re new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let’s get to it…

A Walmart Health clinic with counseling, labs, optometry, primary care, dental, and hearing services.Walmart Health
Walmart’s healthcare leaders are exiting the company as it taps the brakes on an ambitious clinic rollout

  • A number of Walmart’s healthcare leaders have left the company in recent months.
  • Walmart slowed its push into primary care after a recent change in CEOs.
  • Now with 9 key healthcare leaders gone, the clinics are no longer in the spotlight.

Get the full breakdown here>>

Biotechnology company Moderna protocol files for COVID-19 vaccinations are kept at the Research Centers of America in Hollywood, Florida, on August 13, 2020.Photo by CHANDAN KHANNA/AFP via Getty Images

Moderna’s mRNA technology could help in the decades-long search for an HIV vaccine

  • Moderna’s mRNA tech could change the game in the decades-long effort to develop an HIV vaccine.
  • The company said it expects to begin two vaccine trials in humans by the end of 2021.
  • While “excited” by the prospect, HIV researchers caution there’s a long road ahead for mRNA vaccines.

Here’s what’s in store>>

A CVS pharmacist gives the Pfizer/BioNTech COVID-19 vaccine to a resident at the Emerald Court senior living community in Anaheim, California.Paul Bersebach/MediaNews Group/Orange County Register via Getty Images

Primary-care upstarts ChenMed, Iora, and VillageMD are protesting a US decision to halt applications for a potentially lucrative Medicare program

  • A new federal program that aims to lower costs for Medicare kicked off on April 1.
  • The US will no longer take applications from companies that want to take part starting in 2022.
  • Clinics and doctor groups are urging the feds to reconsider.

They’re calling the decision a “serious blow”>>

More stories we’re reading:

  • Diabetes care startup Virta Health raises $133 million in a round led by Tiger Global, valuing it at $2 billion (Forbes)
  • A record 5.2 million people globally tested positive for COVID-19 last week, despite the vaccine rollout ramping up in wealthy nations (Insider)
  • It might be time to reevaluate why we wear masks outside (The Atlantic) 
  • Half of US adults have had at least one dose of a COVID-19 vaccine, the CDC says (Insider)
  • NASA’s Mars helicopter took flight for the first time, opening the door for a new generation of space drones (Insider)

– Lydia

Source: Read Full Article